top of page

POSTERS

2025 Loera CPRED x26 AAPP
2024 Hill AMERSA
2024 Zagorski AMERSA
Opioid antagonist knowledge, preferences, and practices among substance use service providers in Tex
Texas community pharmacist perspectives and knowledge on buprenorphine dispensing for opioid use dis
A survey of opioid overdose preparedness in Texas school districts
Exploring opportunities to expand naloxone access and save lives on campus
Accessibility of office-based buprenorphine treatment for opioid use disorder in Texas
Evaluation of injection drug use and wound care practices of a mobile syringe services program
Policies and recommendation frequencies for medications for opiid use disorder in professional recov
Impact of a community immersion experience on student pharmacists' associated stigma of serious ment
Impact of interprofessional substance use disorder education on students' perceptions of addiction a
A wound care and immunization needs assessment for clients of a mobile syringe services program in A
Buprenorphine/naloxone film and naloxone nasal spray pharmacy deserts in Harris County, Texas and Ph
A qualitative report of fentanyl exposure among people who use drugs in Austin, Texas
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in ele
Analysis of Clinical Characteristics of Travis County Patients in a Central Texas Outpatient Substan
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Pen
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Ari
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Sou
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Flo
Availability of buprenorphine/naloxone films in naloxone nasal spray in community pharmacies in Cali
Policies regarding use of medications for opioid use disorder in professional recovery programs: A s
Analysis of student pharmacists' self-reported intention to provide harm reduction resources after b
Description and Evaluation of a Novel Advanced Pharmacy Practice Experience (APPE) in Addiction Medi
Pedagogical Approaches to Optimizing Opioid-Related Outcomes: The Texas Opioid Training Initiative
Analysis of Patient-Reported Satisfaction with Long-Acting Injectables for Opioid and Alcohol Use Di
Isotonitazene as a contaminant of concern in the illegal opioid supply: a practical synthesis and co
bottom of page